240 related articles for article (PubMed ID: 22525194)
1. An in silico chimeric multi subunit vaccine targeting virulence factors of enterotoxigenic Escherichia coli (ETEC) with its bacterial inbuilt adjuvant.
Nazarian S; Mousavi Gargari SL; Rasooli I; Amani J; Bagheri S; Alerasool M
J Microbiol Methods; 2012 Jul; 90(1):36-45. PubMed ID: 22525194
[TBL] [Abstract][Full Text] [Related]
2. Construction and expression of immunogenic hybrid enterotoxigenic Escherichia coli CFA/I and CS2 colonization fimbriae for use in vaccines.
Tobias J; Svennerholm AM; Holmgren J; Lebens M
Appl Microbiol Biotechnol; 2010 Jul; 87(4):1355-65. PubMed ID: 20405124
[TBL] [Abstract][Full Text] [Related]
3. Significance of Enterotoxigenic Escherichia coli (ETEC) Heat-Labile Toxin (LT) Enzymatic Subunit Epitopes in LT Enterotoxicity and Immunogenicity.
Huang J; Duan Q; Zhang W
Appl Environ Microbiol; 2018 Aug; 84(15):. PubMed ID: 29802193
[TBL] [Abstract][Full Text] [Related]
4. In Silico designing and immunogenic production of the multimeric CfaB*ST, CfaE, LTB antigen as a peptide vaccine against Enterotoxigenic Escherichia coli.
Asmani F; Khavari-Nejad RA; Salmanian AH; Amani J
Microb Pathog; 2021 Sep; 158():105087. PubMed ID: 34256098
[TBL] [Abstract][Full Text] [Related]
5. Designing and structure evaluation of multi-epitope vaccine against ETEC and EHEC, an in silico approach.
Jeshvaghani FS; Rahjerdi AK; Amani J; Rad I; Jafari M; Salmanian AH
Protein Pept Lett; 2016; 23(1):33-42. PubMed ID: 26497319
[TBL] [Abstract][Full Text] [Related]
6. Design and characterization of a chimeric multiepitope construct containing CfaB, heat-stable toxoid, CssA, CssB, and heat-labile toxin subunit B of enterotoxigenic Escherichia coli: a bioinformatic approach.
Zeinalzadeh N; Salmanian AH; Ahangari G; Sadeghi M; Amani J; Bathaie SZ; Jafari M
Biotechnol Appl Biochem; 2014; 61(5):517-27. PubMed ID: 24372617
[TBL] [Abstract][Full Text] [Related]
7. Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates.
Tobias J; Svennerholm AM
Appl Microbiol Biotechnol; 2012 Mar; 93(6):2291-300. PubMed ID: 22350259
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of a fusion protein comprising coli surface antigen 3 and labile B subunit of enterotoxigenic Escherichia coli.
Alerasol M; Mousavi Gargari SL; Nazarian S; Bagheri S
Iran Biomed J; 2014; 18(4):212-218. PubMed ID: 25326019
[TBL] [Abstract][Full Text] [Related]
9. Construction and immunogenic properties of a chimeric protein comprising CfaE, CfaB and LTB against Enterotoxigenic Escherichia coli.
Gheibi Hayat SM; Mousavi Gargari SL; Nazarian S
Biologicals; 2016 Nov; 44(6):503-510. PubMed ID: 27733309
[TBL] [Abstract][Full Text] [Related]
10. A PLGA-encapsulated chimeric protein protects against adherence and toxicity of enterotoxigenic Escherichia coli.
Nazarian S; Gargari SL; Rasooli I; Hasannia S; Pirooznia N
Microbiol Res; 2014; 169(2-3):205-12. PubMed ID: 23906742
[TBL] [Abstract][Full Text] [Related]
11. Identification of epitope-based peptide vaccine candidates against enterotoxigenic Escherichia coli: a comparative genomics and immunoinformatics approach.
Mehla K; Ramana J
Mol Biosyst; 2016 Mar; 12(3):890-901. PubMed ID: 26766131
[TBL] [Abstract][Full Text] [Related]
12. Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans.
Zhang W; Sack DA
Expert Rev Vaccines; 2012 Jun; 11(6):677-94. PubMed ID: 22873126
[TBL] [Abstract][Full Text] [Related]
13. Over-expression of major colonization factors of enterotoxigenic Escherichia coli, alone or together, on non-toxigenic E. coli bacteria.
Tobias J; Holmgren J; Hellman M; Nygren E; Lebens M; Svennerholm AM
Vaccine; 2010 Oct; 28(43):6977-84. PubMed ID: 20728524
[TBL] [Abstract][Full Text] [Related]
14. Review on pathogenicity mechanism of enterotoxigenic Escherichia coli and vaccines against it.
Mirhoseini A; Amani J; Nazarian S
Microb Pathog; 2018 Apr; 117():162-169. PubMed ID: 29474827
[TBL] [Abstract][Full Text] [Related]
15. [Advances in new vaccines against human enterotoxigenic Escherichia coli--A review].
Xia P; Meng X; Zhu G
Wei Sheng Wu Xue Bao; 2016 Feb; 56(2):198-208. PubMed ID: 27373068
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Mucosal Immune Responses to Enterotoxigenic Escherichia coli Vaccine Antigens in a Human Challenge Model: Response Profiles after Primary Infection and Homologous Rechallenge with Strain H10407.
Chakraborty S; Harro C; DeNearing B; Ram M; Feller A; Cage A; Bauers N; Bourgeois AL; Walker R; Sack DA
Clin Vaccine Immunol; 2016 Jan; 23(1):55-64. PubMed ID: 26581889
[TBL] [Abstract][Full Text] [Related]
17. Vaccines for enterotoxigenic Escherichia coli: current status.
Boedeker EC
Curr Opin Gastroenterol; 2005 Jan; 21(1):15-9. PubMed ID: 15687879
[TBL] [Abstract][Full Text] [Related]
18. Directed evaluation of enterotoxigenic Escherichia coli autotransporter proteins as putative vaccine candidates.
Harris JA; Roy K; Woo-Rasberry V; Hamilton DJ; Kansal R; Qadri F; Fleckenstein JM
PLoS Negl Trop Dis; 2011 Dec; 5(12):e1428. PubMed ID: 22163060
[TBL] [Abstract][Full Text] [Related]
19. A Chimeric protein of CFA/I, CS6 subunits and LTB/STa toxoid protects immunized mice against enterotoxigenic Escherichia coli.
Zeinalzadeh N; Salmanian AH; Goujani G; Amani J; Ahangari G; Akhavian A; Jafari M
Microbiol Immunol; 2017 Jul; 61(7):272-279. PubMed ID: 28543534
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with EtpA glycoprotein or flagellin protects against colonization with enterotoxigenic Escherichia coli in a murine model.
Roy K; Hamilton D; Ostmann MM; Fleckenstein JM
Vaccine; 2009 Jul; 27(34):4601-8. PubMed ID: 19523914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
